Company waiting for results of initial tests
The operator of the Almaraz and Trillio nuclear power stations in Spain is collaborating with French nuclear company Framatome on the possible commercial production at the Trillo power plant of the radioisotope lutetium-177 (Lu-177), which is used in nuclear medicine for the treatment of tumours.
Want to know more?
Sign up.
- Independent news and information for and about the global nuclear industry
- For nuclear incidents, NucNet operates 24 hours a day, 7 days a week
- Daily, weekly and monthly newsletters
- Access to infographics for subscribers to use in their own editorial and marketing material
- Exclusive analysis and special reports on key nuclear industry topics
- Breaking news on social media
- Access to the 'NucNet Style Guide for Nuclear Reporters and Communicators'
- Access to NucNet editorial database containing more than 18,000 news articles and features from January 1991
- A reliable media and communications partner for the nuclear energy industry. Distribution of your industry news stories
- Manage your own preferences
- Get involved. Members can attend meetings and be part of NucNet's policy and editorial decision-making
Start Free Trial
